Potassium Carbonate → 1-[1-(6-Chloro-pyridazin-3-yl)-piperidin-4-yl]-4-(4-methanesulfonyl-phenoxy)-1H-pyrazolo[3,4-d]pyrimidine

HRID 1931735Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1931735
[Cl:1][C:2]1[N:3]=[N:4][C:5](Cl)=[CH:6][CH:7]=1.FC(F)(F)C(O)=O.[CH3:16][S:17]([C:20]1[CH:41]=[CH:40][C:23]([O:24][C:25]2[N:30]=[CH:29][N:28]=[C:27]3[N:31]([CH:34]4[CH2:39][CH2:38][NH:37][CH2:36][CH2:35]4)[N:32]=[CH:33][C:26]=23)=[CH:22][CH:21]=1)(=[O:19])=[O:18].C(=O)([O-])[O-].[K+].[K+].[Cl-].[NH4+]>CN(C)C=O>[Cl:1][C:2]1[N:3]=[N:4][C:5]([N:37]2[CH2:38][CH2:39][CH:34]([N:31]3[C:27]4=[N:28][CH:29]=[N:30][C:25]([O:24][C:23]5[CH:22]=[CH:21][C:20]([S:17]([CH3:16])(=[O:18])=[O:19])=[CH:41][CH:40]=5)=[C:26]4[CH:33]=[N:32]3)[CH2:35][CH2:36]2)=[CH:6][CH:7]=1

Komponenten

6

Reaktionsbedingungen

Temperatur
60 °C

Versuchsvorschrift

3,6-Dichloropyridazine (0.2 mmol) was added to a mixture of 4-(4-methanesulfonyl-phenoxy)-1-piperidin-4-yl-1H-pyrazolo[3,4-d]pyrimidine trifluoroacetate salt (Intermediate 27; 75 mg, 0.15 mmol) and potassium carbonate (69 mg, 0.5 mmol) in dimethylformamide (1 mL). The mixture was heated to 60° C. overnight and then poured into saturated aqueous ammonium chloride solution. This mixture was extracted three times with ethyl acetate. The combined organic phases were washed twice with water and once with brine, dried (magnesium sulfate), filtered, evaporated, and purified on a silica gel column, eluting with ethyl acetate, to give 1-[1-(6-Chloro-pyridazin-3-yl)-piperidin-4-yl]-4-(4-methanesulfonyl-phenoxy)-1H-pyrazolo[3,4-d]pyrimidine (0.5 mg, 0.7%) as a white powder.

Aufarbeitung

  1. extractionThis mixture was extracted three times with ethyl acetate
  2. washThe combined organic phases were washed twice with water and once with brine
  3. dry with materialdried (magnesium sulfate)
  4. filtrationfiltered
  5. customevaporated
  6. custompurified on a silica gel column
  7. washeluting with ethyl acetate

Quellen und Nachweise

ORD-Eintrag
ord-cb9647f5187543889a23e77e25aface9
Quelldatensatz
uspto-grants-2012_05
Patentnummer
US08188098B2

Notizen zur Reaktion

Wird geladen…